Publisher
Springer Berlin Heidelberg
Reference157 articles.
1. Babjuk M, Burger M, et al., Eds. (2017). EAU Guidelines on non-muscle invasive bladder cancer (Ta,T1 and CIS). European Association of Urology Guidelines. Arnhem, EAU Guidelines Office.
2. Babjuk M, Kostirova M, et al. (2002). «Qualitative and quantitative detection of urinary human complement factor H-related protein (BTA stat and BTA TRAK) and fragments of cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as markers for transitional cell carcinoma of the bladder.» Eur Urol 41: 34-39.
3. Berezney R and Coffey DS (1974). «Identification of a nuclear protein matrix.» Biochem Biophys Res Comm 60: 1410-1414.
4. Bollmann M, Heller H, et al. (2005). «Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?» BJU Int 95(9): 1219-25.
5. Boman H, Hedelin H, et al. (2002). «Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumour marker set.» J Urol 168(5): 1955-1959.